cms_WV: 2898

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
2898 E.A. HAWSE NURSING AND REHABILITATION CENTER 515173 18086 STATE ROUTE 55 BAKER WV 26801 2019-02-14 758 D 0 1 SV8C11 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on medical record review and staff interview, the facility failed in collaboration with the pharmacist, to consult the physician for an annual evaluation for gradual dose reduction of psychoactive medications. This was evident for two (2) of five (5) residents reviewed for unnecessary medications. Resident identifiers: #15, #25. Facility census: 53. Findings included: a) Resident #15 Medical record review on 02/13/19 found this resident received [MEDICATION NAME] 75 milligrams (mg) twice daily. [MEDICATION NAME] is a psychoactive medication used for the treatment of [REDACTED]. Further review of the medical record found the most recent pharmacy recommendation to consider a gradual dose reduction (GDR) occurred sixteen (16) months ago on 10/22/17. The pharmacist at that time addressed that this resident has been taking [MEDICATION NAME] 75 mg. twice daily since 01/30/14. The pharmacist requested the physician to evaluate for the lowest effective dose. The physician declined the option of a dose reduction at that time, with instructions to see his progress notes for the rationale. Review of the medical record found no evidence that the pharmacist made any requests in (YEAR) or through the current date, for the physician to again evaluate for the lowest effective dose of this medication. An interview was conducted with the administrator and the director of nursing on 02/14/19 at 8:45 AM. They said there was no other pharmacy irregularity report/consult to the physician for a consideration for dose reduction of the [MEDICATION NAME] since 10/22/17. They said the physician did not order contraindications for future considerations for GDR of the [MEDICATION NAME], or note previous failures of a GDR. b) Resident #25 A review of the pharmacist recommendation for Resident #25, revealed the pharmacist made a recommendation for a GDR for the medication [MEDICATION NAME] 0.5 milligram (mg) at night for Dementia with Lewy Bodies. Resident #25 has been on the [MEDICATION NAME] since 07/20/16. The pharmacist asked the physician to please evaluate for the lowest possible dose and consider a dosage reduction at this time on 07/24/17. The physician agreed with the pharmacist and the [MEDICATION NAME] medication was discontinued on 08/02/17. On 08/23/17 the medication [MEDICATION NAME] 0.5 mg at night was restarted. A record review on 02/14/19 at 8:50 AM, finds Resident #25 is currently on [MEDICATION NAME] 0.5 mg at night for Dementia with Lewy Bodies. On 02/14/19 at 8:55 AM, a review of the pharmacist recommendation for Resident #25, revealed the pharmacist had not make a recommendation for a GDR for the [MEDICATION NAME] 0.5 mg at night, since 07/24/17. The Director of Nursing (DON) #120, and the Administrator #110 on 02/14/19 at 9:00 AM, agreed the pharmacist did not make a annual recommendation for a GDR on Resident #25's [MEDICATION NAME]. The DON and the Administrator confirmed the last GDR for Resident #25's [MEDICATION NAME] was on 07/24/17. 2020-09-01